The Equity Split You Agreed to on a Napkin Will End Your Company in Year Three
That informal equity split you shook hands on feels fine now. Here's exactly why it becomes a catastrophic problem the moment real money shows up.
W. OseiFrom Bench to Business
Before you put a customer logo in your pitch deck, understand exactly what that relationship actually means and what they'll say when investors call.
W. OseiYour scientific advisor's undisclosed competing interests can blow up a funding round or partnership deal. Here's what to find before it's too late.
W. OseiYour monthly investor update feels like good practice, but the way most founders write it quietly closes doors before the next round even opens.
W. OseiThe cap table mistakes deep tech founders make at seed stage don't show up until Series A, when they're nearly impossible to fix.
W. OseiWhen a big company asks for your technical data package, they're not always serious buyers. Here's how to tell the difference and protect yourself.
W. OseiBefore you sign that exclusive license from your university tech transfer office, understand exactly which clauses will make you unfundable and unsellable.
W. OseiThat MOU from a big corporate partner feels like validation, but it's often a delay mechanism. Here's how to tell the difference and what to do about it.
W. OseiThat NDA from your potential industry partner looks standard. It probably isn't. Here's what deep tech founders miss before they sign.
W. OseiYour clinical advisor is brilliant and respected. But if they can't talk reimbursement codes, they may be the most expensive hire you never paid for.
W. OseiYour lab prototype proves the science works. It proves almost nothing about whether you can build a real product. Here's what changes between bench and shelf.
W. OseiMost deep tech founders sign term sheets they don't fully understand. Here's what the standard clauses actually mean for your startup's future.
W. OseiMost deep tech founders build their investor data room to impress, not to close. Here's why that instinct backfires and what to do instead.
W. OseiThat pilot deal with your first big customer feels like validation. It might actually be the contract that kills your startup's growth before it starts.
W. OseiMost deep tech founders outsource regulatory strategy too early, and to the wrong people. Here's what that mistake actually costs you.
W. OseiNot every accelerator is built for deep tech founders. Here's how to tell which ones will drain your runway instead of building your company.
W. OseiMost deep tech co-founder agreements are written for friendship, not survival. Here's what goes wrong, and what to fix before investors see your cap table.
W. OseiLicensing your deep tech looks like free money, until the audits, sublicensing traps, and milestone clawbacks hit. Here's what to watch.
W. OseiA customer LOI feels like validation, but it's not a contract, not revenue, and not proof of market fit. Here's what it actually is.
W. OseiBefore you raise a dollar or sign a co-founder, understand who actually owns your invention, because your university might.
W. OseiSBIR grants fund your science, not your startup. Here's why mistaking one for the other is the most common, and costly, mistake in deep tech.
W. OseiGrant funding lets you control every variable. That's exactly why your proof-of-concept data may be telling you a story that doesn't survive first contact with a real market.
W. OseiTechnical founders often tank investor pitches by over-explaining the science. Here's how to translate your research into language that closes rounds.
W. OseiWhat biotech founders really face in their first FDA pre-submission meeting and how to survive the regulatory reality check.
W. OseiTechnical founders face brutal reality when manufacturers suddenly stop responding, here's why it happens and how to avoid it.
W. OseiHow prestigious scientific advisors can kill your deep tech startup with academic thinking and misaligned incentives.
W. OseiWhy that $500K mass spectrometer in your lab doesn't translate to viable manufacturing economics for your startup.
W. OseiWhy university tech transfer offices often sabotage startup dreams and how to fight back with strategy.
W. OseiCommon mistakes technical founders make in early customer interviews and how to avoid turning conversations into product pitches.
W. OseiGraduate school trains you to be a researcher. It does not train you to sell, hire, manage cash flow, or make decisions with incomplete data on a deadline.
W. OseiTechnical founders from academia reliably hit three inflection points where the company almost dies. Recognizing them early does not make them painless, but it makes them survivable.
W. Osei